SCHEMBL7094725

SCHEMBL7094725

CN1C(=O)C(=C2C(=O)Oc3c2cc(CCC(=O)O)cc3C(C)(C)C)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
HPGD P15428 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
DUSP3 P51452 1/20 0.40
MCL1 Q07820 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
FPR1 P21462 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
BRD4 O60885 1/20 0.33
TRPA1 O75762 1/20 0.33
NPC1 O15118 1/20 0.33
MTOR P42345 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094724 1.00 MAPT (0.41) MAPTHPGDALDH1A1KDM4EALOX15
SCHEMBL7636123 0.85 GAA (0.39) ALDH1A1KDM4ERXRARXRBRXRG
SCHEMBL7090861 0.80 NR1H3 (0.45) MAPTHPGDALDH1A1MAPK1FPR1
SCHEMBL7090860 0.80 NR1H3 (0.45) MAPTHPGDALDH1A1MAPK1FPR1
SCHEMBL7093846 0.79 FLT1 (0.40) PPARDPPARARXRARXRBRXRG
SCHEMBL7093845 0.79 FLT1 (0.40) PPARDPPARARXRARXRBRXRG
SCHEMBL8196580 0.78 PTPN1 (0.43) ALDH1A1RXRARXRBRXRGBRD4
SCHEMBL7092131 0.77 TTR (0.40) MAPTHPGDALDH1A1KDM4EMAPK1
SCHEMBL7092128 0.77 TTR (0.40) MAPTHPGDALDH1A1KDM4EMAPK1
SCHEMBL7636730 0.73 PTPN1 (0.44) ALDH1A1BRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone NESVADBA PETER (CH) 2003-07-03 US disclosed
US-6503937-B1 Coloring agents for high molecular weight materials such as polymers CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-07 US disclosed
EP-1123289-B1 OXOBENZOFURANYLIDE-DIHYDROINDOLONES CIBA SC HOLDING AG (CH) 2002-11-27 EP disclosed
EP-1123289-A1 OXOBENZOFURANYLIDE-DIHYDROINDOLONE Ciba SC Holding AG (CH) 2001-08-16 EP disclosed
WO-2000024736-A1 OXOBENZOFURANYLIDE-DIHYDROINDOLONE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone CYP1B1, CYP1A1, ECI1 MAPT 4204/4885HPGD 257/4885ALDH1A1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.